Clinical Trial Update: A Study of LY2409021 in Participants With Different Levels of Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 trial update of LY2409021 in participants with varying kidney function has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure Chronic
• Renal Insufficiency Chronic

Drugs mentioned

• LY2409021

Snippet

Sponsor: Eli Lilly and Company | Conditions: Kidney Failure, Chronic, Renal Insufficiency, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2018-10-29